StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Filana Therapeutics's ebitda for the twelve months ending Jun 30, 2021 was -$12.72M. For fiscal 2020 it was -$6.42M. The highest annual figure on record is -$3.35M in fiscal 2011.

Annual ebitda

PeriodPeriod endValueChange
FY2020Dec 31, 2020-$6.42M–
FY2019Dec 31, 2019-$4.90M–
FY2018Dec 31, 2018-$6.59M–
FY2017Dec 31, 2017-$11.88M–
FY2016Dec 31, 2016-$14.90M–
FY2015Dec 31, 2015-$14.16M–
FY2014Dec 31, 2014-$12.42M–
FY2012Dec 31, 2012-$3.78M–
FY2011Dec 31, 2011-$3.35M–
FY2010Dec 31, 2010-$13.47M–
FY2009Dec 31, 2009-$6.50M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2021Jun 30, 2021-$5.13M–
Q1 FY2021Mar 31, 2021-$3.53M–
Q4 FY2020Dec 31, 2020-$2.62M–
Q3 FY2020Sep 30, 2020-$1.44M–
Q2 FY2020Jun 30, 2020-$1.16M–
Q1 FY2020Mar 31, 2020-$1.21M–
Q4 FY2019Dec 31, 2019-$1.56M–
Q3 FY2019Sep 30, 2019-$765.00K–
Q2 FY2019Jun 30, 2019-$1.14M–
Q1 FY2019Mar 31, 2019-$1.43M–
Q4 FY2018Dec 31, 2018-$733.00K–
Q3 FY2018Sep 30, 2018-$1.27M–
Q2 FY2018Jun 30, 2018-$2.44M–
Q1 FY2018Mar 31, 2018-$2.15M–
Q4 FY2017Dec 31, 2017-$2.41M–
Q3 FY2017Sep 30, 2017-$2.58M–
Q2 FY2017Jun 30, 2017-$4.15M–
Q1 FY2017Mar 31, 2017-$2.75M–
Q4 FY2016Dec 31, 2016-$2.53M–
Q3 FY2016Sep 30, 2016-$3.53M–

More Filana Therapeutics figures

See a number that looks wrong?